Abstract
AimsThe arrival of anti-vascular endothelial growth factor (anti-VEGF) therapies represented a treatment shift for several ophthalmological disorders and led to an increasing number of patients undergoing intravitreal injections. The aims...
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have